ClinicalTrials.Veeva

Menu

Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

Thomas Jefferson University logo

Thomas Jefferson University

Status

Withdrawn

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Treatments

Procedure: Magnetic Resonance Imaging
Procedure: Computed Tomography
Other: Questionnaire Administration
Other: Best Practice
Other: Virtual Technology Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05600556
JT 20764 (Other Identifier)
22C.714

Details and patient eligibility

About

This clinical trial explores if using virtual reality (VR) headsets will help to improve patient understanding of their disease and decrease anxiety about treatment. Three-dimensional (3D) images may help the patient visualize their tumor and location better and therefore understand potential side effects. Visualizing a virtual representation of the magnetic resonance imaging (MRI) linear accelerator (Linac) may decrease treatment related anxiety.

Full description

PRIMARY OBJECTIVE:

I. Examine patient reported comprehension of their tumor characteristics and treatment plan following 3D virtual reality review of their imaging.

SECONDARY OBJECTIVE:

I. Examine patient reported treatment related anxiety prior to and following virtual reality (VR) simulation of the MRI Linac treatment process.

OUTLINE: Patients are assigned to 1 of 2 cohorts.

COHORT I: Patients receive two-dimensional (2D) image review using standard computer screen on study. Patients undergo MRI and computed tomography (CT) imaging at screening and on study.

COHORT II: Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: above 18 years
  • Participants must be histologically proven neoplasm
  • Planned to undergo radiation treatment using the MR Linac

Exclusion criteria

  • Inability to tolerate virtual reality headset
  • Non-English speaking patients
  • Pediatric patients are ineligible

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Cohort I (standard imaging)
Active Comparator group
Description:
Patients receive 2D image review using standard computer screen on study. Patients undergo MRI and CT imaging at screening and on study
Treatment:
Other: Best Practice
Other: Questionnaire Administration
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Other: Questionnaire Administration
Cohort II (virtual reality)
Experimental group
Description:
Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study
Treatment:
Other: Virtual Technology Intervention
Other: Questionnaire Administration
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Other: Questionnaire Administration

Trial contacts and locations

1

Loading...

Central trial contact

Adam Mueller, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems